fluconazole has been researched along with Cystic Fibrosis in 7 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient in this case responded to isavuconazole treatment for breakthrough infection due to B raffinosifermentans that was cultured from pleural fluid while on posaconazole prophylaxis post-bilateral lung transplantation for cystic fibrosis." | 5.12 | Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature. ( Al-Obaidi, M; Badali, H; Cañete-Gibas, C; Patterson, HP; Wiederhold, NP, 2021) |
| "Invasive candidiasis is rare in children after the neonatal period, but can occur in children with (secondary) immunodeficiency with a damaged gastrointestinal or skin barrier, or when receiving antibiotics." | 1.37 | Osteoarticular infection by Candida albicans in an infant with cystic fibrosis. ( Abele-Horn, M; Beer, M; Hebestreit, H; Kunzmann, S; Radike, K, 2011) |
| "Fluticasone was discontinued, and the patient's adrenal function normalized." | 1.37 | Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor. ( Britton, LJ; Gardner, J; Gutierrez, H; Hoover, WC; Jackson, T, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lepesqueur, LSS | 1 |
| Tanaka, MH | 1 |
| Lima, GMG | 1 |
| Chiba, SM | 1 |
| Mota, AJ | 1 |
| Santos, SF | 1 |
| Koga-Ito, CY | 1 |
| Al-Obaidi, M | 1 |
| Badali, H | 1 |
| Cañete-Gibas, C | 1 |
| Patterson, HP | 1 |
| Wiederhold, NP | 1 |
| Demers, EG | 1 |
| Biermann, AR | 1 |
| Masonjones, S | 1 |
| Crocker, AW | 1 |
| Ashare, A | 1 |
| Stajich, JE | 1 |
| Hogan, DA | 1 |
| Radike, K | 1 |
| Kunzmann, S | 1 |
| Abele-Horn, M | 1 |
| Beer, M | 1 |
| Hebestreit, H | 1 |
| Hoover, WC | 1 |
| Britton, LJ | 1 |
| Gardner, J | 1 |
| Jackson, T | 1 |
| Gutierrez, H | 1 |
| Gammelsrud, KW | 1 |
| Lindstad, BL | 1 |
| Gaustad, P | 1 |
| Ingebretsen, A | 1 |
| Høiby, EA | 1 |
| Brandtzaeg, P | 1 |
| Sandven, P | 1 |
| Levy, PY | 1 |
| Habib, G | 1 |
| Reynaud-Gaubert, M | 1 |
| Raoult, D | 1 |
| Rolain, JM | 1 |
1 review available for fluconazole and Cystic Fibrosis
| Article | Year |
|---|---|
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Female; Fluconazole; Genes, Fungal; Human | 2021 |
6 other studies available for fluconazole and Cystic Fibrosis
| Article | Year |
|---|---|
Oral prevalence and antifungal susceptibility of Candida species in cystic fibrosis patients.
Topics: Adolescent; Antifungal Agents; Candida; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, F | 2020 |
Evolution of drug resistance in an antifungal-naive chronic
Topics: Alleles; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Cystic Fibrosis; Drug Resistance, | 2018 |
Osteoarticular infection by Candida albicans in an infant with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidemia; Candidiasis, Invasive; Cystic Fibro | 2011 |
Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenal Insufficiency; Androstadienes; Anti-Ast | 2011 |
Multilocus sequence typing of serial Candida albicans isolates from children with cancer, children with cystic fibrosis and healthy controls.
Topics: Adenoids; Adolescent; Antifungal Agents; Candida albicans; Candidiasis; Case-Control Studies; Child; | 2012 |
Pericardial effusion due to Cryptococcus neoformans in a patient with cystic fibrosis following lung transplantation.
Topics: Adult; Antifungal Agents; Cardiac Tamponade; Cryptococcosis; Cryptococcus neoformans; Cystic Fibrosi | 2008 |